# PolyPhotonix Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/polyphotonix-medical

- Industry: Medical Devices & Equipment
- Headquarters: UK
- Website: www.polyphotonix.com
- Total disclosed funding: $10M
- Latest round: Series A (Jan 20, 2022)
- Investors on record: 1

## About

Based in Durham, UK, and founded in 2009, PolyPhotonix Medical Ltd. is a medical device manufacturer that designs and develops non-invasive photonic-based medical devices to cure and prevent diabetic retinopathy, a condition that can lead to blindness in diabetic patients. As of 2023, the company is led by its CEO, Richard Kirk. In January 2022, investor Prevail Partners led a USD 10 million Series A funding round for PolyPhotonix Medical Ltd.

The company has developed the Noctura 400 Sleep Mask, a patented, non-invasive treatment for diabetic retinopathy that can treat and prevent diabetic retinopathy, a condition that can lead to blindness in diabetics. The sleep mask decreases and reverses the effects of diabetic retinopathy by giving light treatment during a patient's normal sleeping hours at home.

## Funding rounds

- Series A, Jan 20, 2022, $10M — Prevail Partners

## Investors

- Prevail Partners (https://capitalatlas.ai/funds/prevail-partners) — Series A